CancerX shared on LinkedIn:
“Your pilot went great. Everyone said so.
That was 14 months ago.
No enterprise contract. No expansion. Just a warm email thread that slowly went cold.
We call it the pilot graveyard, where good oncology tech goes to be congratulated.
The fix usually isn’t a better demo. It’s deployment terms, clinical champions, and an evidence plan designed in from day one, with the health system at the table.
That’s what the CancerX Accelerator is built around:
- business strategy that balances clinical benefit for patients with financial sustainability for your partners,
- compressed timelines for validation and testing,
- faster conversations across clinical, management and innovation teams.
All aimed at getting great oncology tech past the pilot and into everyday care.
If this post stung a little, it was written for you.
Apply to the CancerX Accelerator 2027 Cohort by signing in to your Constellation account.”
Other articles about CancerX on OncoDaily.